Results 151 to 160 of about 14,735 (228)

Expression and function of CYP enzymes and hepatobiliary transporters in an improved long-term sandwich culture hepatocyte model. [PDF]

Sci Rep
Pacsuta J, Bárány N, Kiszelák K, Csíkvári O, Mártonné Tóth B, Jemnitz K, Gáborik Z.   +6 more
europepmc   +1 more source

Genetic Polymorphisms and <i>in Vitro</i> Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants

, 2016
Masahiro Hiratsuka
openalex   +2 more sources

CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel [PDF]

, 2013
Daniel L. Hertz, S Roy, Alison A. Motsinger‐Reif, Amy Drobish, L. Scott Clark, Howard L. McLeod, Lisa A. Carey, Elizabeth Claire Dees   +7 more
openalex   +1 more source

Towards Personalized Chemotherapy in Gastrointestinal Cancers: Prospective Analysis of Pharmacogenetic Variants in a Russian Cohort. [PDF]

Genes (Basel)
Fedorinov D, Lyadov V, Lyadova M, Abdullaev S, Kachanova A, Heydarov R, Shashkov I, Surzhikov S, Mikhailovich V, Sychev D.   +9 more
europepmc   +1 more source

The Role of CYP2C8 and CYP2C9 Genotypes in Losartan‐Dependent Inhibition of Paclitaxel Metabolism in Human Liver Microsomes [PDF]

, 2015
Yuji Mukai, Asuna Senda, Takaki Toda, Erik Eliasson, Anders Rane, Nobuo Inotsume   +5 more
openalex   +1 more source

Protein Levels of 16 Cytochrome P450s and 2 Carboxyl Esterases Using Absolute Quantitative Proteomics: CYP2C9 and CYP3A4 Are the Most Abundant Isoforms in Human Liver and Intestine, Respectively. [PDF]

Pharmaceuticals (Basel)
Grangeon A, Arwood ML, Thacker D, Gaudette F, Turgeon J, Michaud V.   +5 more
europepmc   +1 more source

Drug-drug interactions with pioglitazone, losartan, and midazolam and anti-tumor efficacy and safety study of TAS-115 in patients with solid tumors. [PDF]

Cancer Chemother Pharmacol
Katsuya Y, Takenaka S, Takahashi S, Yamamoto N.   +3 more
europepmc   +1 more source

Tyrosine-kinase inhibitors for lung or breast cancer and drug-drug interactions: a clinical guide. [PDF]

Oncol Rev
Santamaria F, Roberto M, Maltese G, Nicolella F, Torchia A, Buccilli D, Di Civita MA, Giancontieri P, Marinelli D, Cirillo A, Bianco V, Verrico M, Botticelli A, Santini D.   +13 more
europepmc   +1 more source

In Vitro Inhibitory Effects and Molecular Mechanism of Four Theaflavins on Isozymes of CYP450 and UGTs. [PDF]

Foods
Hu L, Hu Z, Peng J, Hou A, Hao Z, Wu Z, Li Y, Li K, Li Z, Liu Z, Xiao Y, Wang Y.   +11 more
europepmc   +1 more source

Physiologically Based Pharmacokinetic Modeling to Assess Perpetrator and Victim Cytochrome P450 2C Induction Risk. [PDF]

Pharmaceutics
Slavsky M, Karve AS, Hariparsad N.
europepmc   +1 more source